Benzinga | Mar 2, 2021 04:03PM EST

TransMedics Group Q4 EPS $(0.23) Beats $(0.25) Estimate, Sales $7.60M Beat $6.04M Estimate

TransMedics Group (NASDAQ:TMDX) reported quarterly losses of $(0.23) per share which beat the analyst consensus estimate of $(0.25) by 8 percent. This is a 46.51 percent increase over losses of $(0.43) per share from the same period last year. The company reported quarterly sales of $7.60 million which beat the analyst consensus estimate of $6.04 million by 25.83 percent. This is a 25.47 percent increase over sales of $6.06 million the same period last year.